GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $11.21 $12.67 Friday, 19th Apr 2024 DVAX stock ended at $11.80. This is 4.06% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 5.33% from a day low at $11.25 to a day high of $11.85.
90 days $11.21 $14.30
52 weeks $10.20 $15.15

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
2024-03-14 $12.10 $12.18 $11.90 $12.02 1 745 801
2024-03-13 $12.66 $12.70 $12.03 $12.17 2 657 560
2024-03-12 $12.94 $12.95 $12.63 $12.64 1 675 935
2024-03-11 $13.08 $13.26 $12.91 $12.97 1 347 261
2024-03-08 $12.92 $13.27 $12.91 $13.14 1 379 987
2024-03-07 $12.75 $12.93 $12.58 $12.82 1 553 277
2024-03-06 $12.59 $12.77 $12.44 $12.73 1 504 444
2024-03-05 $12.69 $12.77 $12.53 $12.57 1 466 159
2024-03-04 $12.71 $12.79 $12.56 $12.74 1 196 446
2024-03-01 $12.72 $12.91 $12.63 $12.76 1 442 350
2024-02-29 $13.03 $13.08 $12.60 $12.67 1 751 627
2024-02-28 $12.89 $13.09 $12.85 $12.95 1 164 854
2024-02-27 $13.13 $13.20 $12.84 $12.99 2 476 862
2024-02-26 $12.70 $13.19 $12.64 $13.14 2 855 600
2024-02-23 $12.47 $13.06 $12.27 $12.75 3 039 094
2024-02-22 $12.51 $12.61 $12.30 $12.44 2 120 300
2024-02-21 $12.14 $12.48 $12.12 $12.46 1 523 309
2024-02-20 $12.35 $12.44 $12.08 $12.28 1 735 335
2024-02-16 $12.43 $12.58 $12.33 $12.41 1 461 239
2024-02-15 $12.47 $12.56 $12.35 $12.48 1 443 053
2024-02-14 $12.42 $12.50 $12.21 $12.48 1 523 494
2024-02-13 $12.55 $12.55 $12.18 $12.29 2 451 811
2024-02-12 $12.83 $12.94 $12.78 $12.82 1 358 810
2024-02-09 $12.92 $12.98 $12.82 $12.92 1 268 539
2024-02-08 $12.86 $12.94 $12.80 $12.88 1 545 958
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT